LPTX LEAP THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in LEAP THERAPEUTICS INC (LPTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2022 Q2)
Avg. % of fund
0.01%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 30,664 +16,636 +118.6% 0.00% $14K
2025 Q2 REDUCED 14,028 -23,168 -62.3% 0.00% $4K
2024 Q1 ADDED 37,196 +24,806 +200.2% 0.01% $99K
2023 Q3 REDUCED 12,390 -62,825 -83.5% 0.00% $17K
2022 Q2 INITIATED 75,215 0.04% $86K
% of Fund (quarterly)
← Back to XTX Topco Ltd Holdings